Aethlon Medical, Inc. (OTCMKTS:AEMD) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday.

Shares of Aethlon Medical (AEMD) opened at 0.971 on Wednesday. The company’s 50 day moving average price is $1.56 and its 200 day moving average price is $1.98. Aethlon Medical has a one year low of $0.90 and a one year high of $5.18. The stock’s market capitalization is $8.64 million.

Aethlon Medical (OTCMKTS:AEMD) last released its quarterly earnings results on Thursday, August 10th. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.05). On average, equities analysts expect that Aethlon Medical will post ($0.50) earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “ValuEngine Downgrades Aethlon Medical, Inc. (AEMD) to Strong Sell” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/11/valuengine-downgrades-aethlon-medical-inc-aemd-to-strong-sell.html.

Aethlon Medical Company Profile

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Receive News & Stock Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related stocks with our FREE daily email newsletter.